(Q36799806)

16 August 2017

High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes (English)

1 reference

16 August 2017

1 reference

Yi Zhang

1

1 reference

16 August 2017

Mae Thamer

2

1 reference

16 August 2017

James S Kaufman

3

1 reference

16 August 2017

Dennis J Cotter

4

1 reference

16 August 2017

Miguel A Hernán

5

1 reference

16 August 2017

language of work or name

English

0 references

publication date

22 June 2011

1 reference

16 August 2017

1 reference

16 August 2017

80

1 reference

16 August 2017

6

1 reference

16 August 2017

663-669

1 reference

Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Potential roles of erythropoietin in the management of anaemia and other complications diabetes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

A structural approach to selection bias

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Effect of erythropoietin on cardiovascular diseases.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Cardiovascular effects of erythropoietin and anemia correction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Marginal structural models and causal inference in epidemiology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988-2004.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Epoetin requirements predict mortality in hemodialysis patients

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Hematocrit, Independent of Chronic Kidney Disease, Predicts Adverse Cardiovascular Outcomes in Chinese Patients With Type 2 Diabetes

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3637948

Correction of anemia with epoetin alfa in chronic kidney disease

4 December 2018

1 reference

12 December 2020

Severity of AIDS and the response to EPO in uremia

1 reference

12 December 2020

A case of erythropoietin induced hypertension in a bilaterally nephrectomized patient

1 reference

12 December 2020

Breast cancer trial with erythropoietin terminated unexpectedly

1 reference

12 December 2020

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.188

7 January 2021

A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.188

7 January 2021

Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.188

7 January 2021

Relationship between epoetin alfa dose and mortality: findings from a marginal structural model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.188

7 January 2021

Identifiers

DOI

10.1038/KI.2011.188

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

21697811

1 reference